These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4212409)

  • 21. Inhibition by tetracyclines of polyuridylic acid directed phenylalanine incorporation in Escherichia coli cell-free systems.
    Laskin AI; May Chan W
    Biochem Biophys Res Commun; 1964; 14():137-42. PubMed ID: 4953740
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline.
    Chow AW; Patten V; Guze LB
    Antimicrob Agents Chemother; 1975 Jan; 7(1):46-9. PubMed ID: 1137358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.
    Barza M; Brown RB; Shanks C; Gamble C; Weinstein L
    Antimicrob Agents Chemother; 1975 Dec; 8(6):713-20. PubMed ID: 1211925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of tetracyclines on teeth and bones.
    Johnson RH; Mitchell DF
    J Dent Res; 1966; 45(1):86-93. PubMed ID: 4955386
    [No Abstract]   [Full Text] [Related]  

  • 25. Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci.
    Minuth JN; Holmes TM; Musher DM
    Antimicrob Agents Chemother; 1974 Oct; 6(4):411-4. PubMed ID: 4157335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential susceptibility to tetracycline, oxytetracycline and doxycycline of the calf pathogens Mannheimia haemolytica and Pasteurella multocida in three growth media.
    Mead A; Lees P; Mitchell J; Rycroft A; Standing JF; Toutain PL; Pelligand L
    J Vet Pharmacol Ther; 2019 Jan; 42(1):52-59. PubMed ID: 30267412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacologic studies with minocycline.
    Bernard B; Yin EJ; Simon HJ
    J Clin Pharmacol New Drugs; 1971; 11(5):332-48. PubMed ID: 4998431
    [No Abstract]   [Full Text] [Related]  

  • 28. The in-vitro activity of doxycycline and minocycline against anaerobic bacteria.
    Robbins M; Marais R; Felmingham D; Ridgway GL
    J Antimicrob Chemother; 1987 Sep; 20(3):379-82. PubMed ID: 3680075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp.
    Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Rodríguez-Tudela JL
    J Clin Microbiol; 2001 Feb; 39(2):525-32. PubMed ID: 11158101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minocycline Inhibits Candida albicans Budded-to-Hyphal-Form Transition and Biofilm Formation.
    Kurakado S; Takatori K; Sugita T
    Jpn J Infect Dis; 2017 Sep; 70(5):490-494. PubMed ID: 28367877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of Brucella spp to tetracycline and its analogues.
    Farrell ID; Hinchliffe PM; Robertson L
    J Clin Pathol; 1976 Dec; 29(12):1097-100. PubMed ID: 827554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical use of tetracyclines in the treatment of periodontal diseases].
    Bokor-Bratić M; Brkanić T
    Med Pregl; 2000; 53(5-6):266-71. PubMed ID: 11089368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida.
    Hospenthal DR; Beckius ML; Floyd KL; Horvath LL; Murray CK
    Ann Clin Microbiol Antimicrob; 2006 Jan; 5():1. PubMed ID: 16390552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro interactions between fluconazole and minocycline against mixed cultures of Candida albicans and Staphylococcus aureus.
    Li H; Zhang C; Liu P; Liu W; Gao Y; Sun S
    J Microbiol Immunol Infect; 2015 Dec; 48(6):655-61. PubMed ID: 24856422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sensitivity to doxycycline (vibramycin) of the microflora isolated from the patients in a therapeutic clinic].
    Tydel'skaia IL; Ptukha RM; Iakovenko SN; Sidorenko RA
    Antibiotiki; 1975 Aug; 20(8):714-7. PubMed ID: 779626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
    Li Y; Nguyen MH; Derendorf H; Cheng S; Clancy CJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2985-7. PubMed ID: 17517840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation in vitro of the antibacterial activity of some antibiotics and chemotherapeutic agents on germs in sputum. I. The tetracyclines].
    Russo R; Pipitone V; De Vanna F; Carrozzo M
    Boll Soc Ital Biol Sper; 1965 Sep; 41(18):1050-2. PubMed ID: 4964184
    [No Abstract]   [Full Text] [Related]  

  • 38. [Appearance of crossed resistance in the tetracyclines and differences in their in vitro activity on bacterial].
    HEISS F
    Medizinische; 1955 Nov; (46):1593-9. PubMed ID: 13287654
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
    Barchiesi F; Spreghini E; Tomassetti S; Della Vittoria A; Arzeni D; Manso E; Scalise G
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2719-27. PubMed ID: 16870764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
    García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
    Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.